Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
NCT00601094
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Lung Cancer
Interventions
BIOLOGICAL:
autologous dendritic cell-adenovirus CCL21 vaccine
Sponsor
Jonsson Comprehensive Cancer Center